Two independent teams of scientists have described microtechnologies that could allow the testing of multiple drugs and drug combinations directly within tumors – both xenografted tumors in animals and tumors that are still within the patients themselves. Read More
WASHINGTON – Among the hundreds of posters and presentations at the American Academy of Neurology (AAN) 67th annual meeting that addressed various aspects of Alzheimer's disease (AD), a little bit of data from Biogen Inc. generated a disproportionate amount of chatter. Read More
